Evidence Hub

Prophylactic intestinal resection following carbon-ion radiotherapy for locally recurrent rectal cancer: a case report

Furuyama T, Takiyama H, Kondo I, Enjyoji M, Hinokida M, Tatsutomi Y, Nakazawa K, Yamada S et al.

Journal of surgical case reports, 2025

Abstract

Treatment of locally recurrent rectal cancer (LRRC) after surgery is often complex and challenging. A 52-year-old man received emergency surgery (Hartmann's procedure) for bowel perforation caused by a huge sigmoid colon cancer, followed by treatment for concurrent advanced lower rectal cancer with neoadjuvant chemoradiotherapy and abdominoperineal resection. A solitary lung metastasis emerged afterwards, and was surgically removed. However, the patient developed LRRC in front of the sacrum. As surgical resection for the local recurrence was considered too invasive, carbon-ion radiotherapy (CIRT) was performed as radical local therapy. Because the surrounding intestine was highly adherent to the tumor and there was a high risk of developing an ulcer, the intestine was prophylactically resected. The patient has remained relapse-free for 2 years and 6 months since the most recent surgery. CIRT for LRRC appears to represent a useful therapeutic option in combination with prophylactic intestinal resection.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free